Yaling Long

1.0k total citations · 1 hit paper
8 papers, 683 citations indexed

About

Yaling Long is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yaling Long has authored 8 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Yaling Long's work include Lung Cancer Treatments and Mutations (5 papers), Cancer Mechanisms and Therapy (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Yaling Long is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer Mechanisms and Therapy (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Yaling Long collaborates with scholars based in China. Yaling Long's co-authors include Wanling Lin, Qian Chu, Kongming Wu, Huan Zhang, Yunkai Yang, Meijuan Huang, Yanying Li, Min Yu, Yuan Chen and Xuansheng Ding and has published in prestigious journals such as Signal Transduction and Targeted Therapy, Cancer Science and Cancer Cell International.

In The Last Decade

Yaling Long

7 papers receiving 681 citations

Hit Papers

Notch signaling pathway: architecture, disease, and thera... 2022 2026 2023 2024 2022 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaling Long China 6 384 170 130 89 77 8 683
Wanling Lin China 5 392 1.0× 159 0.9× 131 1.0× 79 0.9× 79 1.0× 7 701
Yunkai Yang China 5 403 1.0× 180 1.1× 132 1.0× 84 0.9× 82 1.1× 8 735
Kalliopi Tzavlaki Sweden 6 445 1.2× 139 0.8× 144 1.1× 69 0.8× 89 1.2× 7 742
Xiaoming Hou China 19 382 1.0× 175 1.0× 207 1.6× 126 1.4× 111 1.4× 60 747
Ning Yin China 13 452 1.2× 145 0.9× 181 1.4× 97 1.1× 54 0.7× 44 699
Ping Guo China 13 421 1.1× 179 1.1× 181 1.4× 46 0.5× 97 1.3× 23 695
Limin Sun China 15 446 1.2× 287 1.7× 179 1.4× 65 0.7× 63 0.8× 28 729
Chris Siebel United States 4 533 1.4× 119 0.7× 128 1.0× 56 0.6× 97 1.3× 4 804
Cristina Sáiz-Ladera Spain 15 363 0.9× 219 1.3× 151 1.2× 76 0.9× 57 0.7× 28 638
Chenghua Luo China 15 283 0.7× 118 0.7× 84 0.6× 96 1.1× 73 0.9× 59 749

Countries citing papers authored by Yaling Long

Since Specialization
Citations

This map shows the geographic impact of Yaling Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaling Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaling Long more than expected).

Fields of papers citing papers by Yaling Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaling Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaling Long. The network helps show where Yaling Long may publish in the future.

Co-authorship network of co-authors of Yaling Long

This figure shows the co-authorship network connecting the top 25 collaborators of Yaling Long. A scholar is included among the top collaborators of Yaling Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaling Long. Yaling Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Huang, Shanshan, Yaling Long, Yuan Gao, et al.. (2024). Combined inhibition of MET and VEGF enhances therapeutic efficacy of EGFR TKIs in EGFR-mutant non-small cell lung cancer with concomitant aberrant MET activation. Experimental Hematology and Oncology. 13(1). 97–97. 8 indexed citations
3.
Qin, Yi, Yaling Long, Juan Li, et al.. (2023). Real‐world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi‐center study. Cancer Science. 114(6). 2552–2559. 6 indexed citations
4.
Wang, Jiali, Zhirong Jia, Kang Xiao, et al.. (2023). Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway. Pharmaceutical Biology. 62(1). 33–41. 5 indexed citations
5.
Lin, Wanling, Yaling Long, Yunkai Yang, et al.. (2022). Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduction and Targeted Therapy. 7(1). 95–95. 646 indexed citations breakdown →
6.
Long, Yaling, Yuan Tang, Min Yu, et al.. (2021). The influence of STK11 mutation on acquired resistance to immunotherapy in advanced non-small cell lung cancer with Lynch syndrome: a case report and literature review. Annals of Palliative Medicine. 10(6). 7088–7094. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026